CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Open-market sale President & COO sold 18,858 shares at an average $105.34 ($1,986,420)
- 144 Insider Sale of Securities
- 4 Open-market sale President & COO sold 18,245 shares at $98.50 ($1,797,133)
- 4 Open-market buy Chief Executive Officer bought 2,500 shares at $97.39 ($243,481)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Acquisition or sale completed
- 8-K Event Material agreement · New debt or obligation
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Other acquisition Chief Legal Officer & acquired 329 shares (other)
- 4 Other acquisition President & Chief Operating acquired 350 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 267 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 350 shares (other)
- 8-K Event Other events
- 4 Grant or award Director acquired 1,252 shares (grant or award)
- 4 Grant or award Director acquired 1,252 shares (grant or award)
- 4 Grant or award Director acquired 1,252 shares (grant or award)
Page 12 of 115 · 2,300 filings